Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer

SIMPLE SUMMARY: This study aimed to evaluate whether there is a difference in the overall survival (OS) rates of patients with stage IV lung cancer who underwent radiation therapy (RT) depending on the presence or absence of immune checkpoint inhibitors (ICIs). Eighty patients with stage IV lung can...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hidekazu, Ueda, Kazushi, Karita, Masako, Ono, Taiki, Manabe, Yuki, Kajima, Miki, Fujimoto, Koya, Yuasa, Yuki, Shiinoki, Takehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486712/
https://www.ncbi.nlm.nih.gov/pubmed/37686535
http://dx.doi.org/10.3390/cancers15174260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486712/
https://www.ncbi.nlm.nih.gov/pubmed/37686535
http://dx.doi.org/10.3390/cancers15174260

Ejemplares similares